Atlas Trials

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Clinical trial NCT05053308 · WITHDRAWN

Trial details

NCT number
NCT05053308
Sponsor
Seoul National University
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer PainBreakthrough Pain
Start date
2022-12-01
Primary completion
2023-05-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.